#Sustainability #Switzerland #Zurich #Green Chemistry #PharmaBlock

PharmaBlock Hosts Green Chemistry Symposium in Zurich

In the midst of one of the hottest Junes on record in Europe, with relentless heatwaves emphasizing the urgent need for climate action, PharmaBlock held its third Green Chemistry Symposium (GCS) in Zurich. This influential gathering aimed to explore how 'Green Chemistry' and process innovations can accelerate the decarbonization of pharmaceutical production.

The symposium attracted prominent experts from major pharmaceutical firms such as Novartis, Pfizer, Boehringer Ingelheim, Sanofi, AstraZeneca, and academic giants including ETH Zurich and the University of British Columbia. The event fostered an international dialogue focused on sustainable chemistry, process innovation, and the pathways toward a decarbonized pharmaceutical industry.

Dr. Minmin Yang, founder and CEO of PharmaBlock, highlighted the shifting paradigm in the industry. “Green Chemistry is no longer just an environmental initiative; it is evolving into a new engine for pharmaceutical innovation and competitiveness,” she stated. The goal is to bring together global experts from both academia and the pharmaceutical sector to accelerate the adoption of practical technologies that will define the future of sustainable pharmaceutical production.

During the sessions, discussions indicated a notable industry shift from merely improving isolated processes to rethinking pharmaceutical production through integrated green technologies. Experts detailed how continuous flow manufacturing enables a safer, more efficient, and lower CO₂ production. Emerging technologies such as photochemistry, electrochemistry, and AI-driven process development are speeding up reaction optimization and process innovation. Furthermore, advancements in environmentally friendly peptide synthesis, biobased solvents, continuous synthesis, and enzymatic ligation showcase viable routes toward more sustainable manufacturing practices.

The integration of CO₂ accounting early in process development was underscored, along with the importance of strengthening Scope-3 collaboration across the supply chain. These elements are deemed crucial for the long-term sustainability goals of the industry.

PharmaBlock also unveiled its integrated flow manufacturing platform during the symposium. This innovative system combines reactor technology, process chemistry, digital optimization, and manufacturing capabilities, presenting scalable solutions for greener pharma production. Additionally, the company introduced its Continuous Liquid Phase Peptide Synthesis (CF-LPPS) platform, which further emphasizes its commitment to delivering sustainable and efficient pharmaceutical manufacturing solutions.

In conjunction with the symposium, PharmaBlock inaugurated its Swiss Green-Tech Innovation Hub. This hub aims to cultivate a collaborative environment among European pharmaceutical companies and academic institutions, promoting the development and industrialization of sustainable manufacturing technologies.

Having already established itself as an international forum for dialogue, the Green Chemistry Symposium continues to connect industry and academia, facilitating the exchange of ideas and accelerating the adoption of new technologies. This collaboration is critical in steering the pharmaceutical industry toward more sustainable practices and addressing the pressing challenges posed by climate change. As the event concluded, it was clear that initiatives like these contribute significantly to shaping a greener future for the pharmaceutical sector, demonstrating a collective commitment to environmental stewardship while ensuring continued innovation and competitiveness in the industry.